Relief Therapeutics reported that NRx Pharma, had submitted an application for EUA for Aviptadil to the U.S. FDA
On Jun. 2, 2021, RELIEF THERAPEUTICS reported that its collaboration partner, NRx Pharmaceuticals, announced that it had submitted…
On Jun. 2, 2021, RELIEF THERAPEUTICS reported that its collaboration partner, NRx Pharmaceuticals, announced that it had submitted…
On Jun. 2, 2021, Moderna and UNICEF announced that they had signed a long-term agreement for the supply…
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxasメ novel high-density microarray patch (HD-MAP)…
On Jun. 1, 2021, the National Institutes of Health (NIH) announced the first-in-human, Phase 1 trial assessing the…
On Jun. 1, 2021, in a study of 11 medical-mystery patients, an international team of researchers led by…
On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
On Jun. 1, 2021, WHO validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies…
On Jun. 1, 2021, the heads of the world’s predominant global financing, health and trade agencies united to…
On Jun. 1, 2021, the National Institutes of Health announced that it had started a Phase 1/2 clinical…
On Jun. 1, 2021, the WHO announced it had validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving…
On Jun. 1, 2021, AquaBounty Technologies announced the regulatory approval of the Company’s GE Atlantic salmon by Brazil’s…
On Jun. 1, 2021, Moderna announced that it had initiated the rolling submission process with the U.S. Food…
On Jun. 1, 2021, Moderna announced that it had entered into an agreement with Thermo Fisher Scientific for…
On Jun. 1, 2021, CytoDyn announced that Chiral Pharma in the Philippines placed its first purchase order for…
On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
On May 28, 2021, CureVac announced that the independent Data Safety Monitoring Board (DSMB)confirmed that the pivotal Phase…
On May 28, 2021, the University of Oxford announced the launch of a new centre of global research…
On May 28, 2021, Humanigen announced that the company had submitted an application to the FDA requesting Emergency…
On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…
On May 28, 2021, the Oregon Department of Agriculture (ODA) lifted the quarantine on the Oregon mink farm…
On May 28, 2021, Omeros announced preliminary results from the second cohort of critically ill COVID-19 patients treated…
On May 27, 2021, Novartis and Molecular Partners announced the start of the clinical trial EMPATHY, a Phase…
On May 27, 2021, Innovation Pharma announced that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial…
On May 27, 2021, Innovation Pharmaceuticals announced that patient enrollment in the Companyメs 120-patient, Phase 2 clinical trial…
On May 27, 2021, Seattle Children’s researchers published a study that uncovered a deeper understanding of why people…
On May 27, 2021, Sanofi and GlaxoSmithKline started enrolment in their Phase 3 clinical study to assess the…
On May 26, 2021, National Institutes of Health (NIH) scientists reported that the immune system’s attempt to eliminate…
On May 26, 2021, Altimmune announced new results from a preclinical study demonstrating the ability of its AdCOVID…